Institutional Fund
Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Singapore, SingaporeCIK 20323315 filings on record
Portfolio Value
$67.28M
Q1 2026
Holdings
76
Reported positions
New Buys
33
Opened this quarter
QoQ Change
-90.1%
from $678.70M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Alphabet Inc13.3%
- Ase Technology Hldg Co Ltd5.8%
- Ionis Pharmaceuticals Inc4.4%
- Neurocrine Biosciences Inc4.2%
- Axsome Therapeutics Inc4.1%
- Biomarin Pharmaceutical Inc4.1%
- Other64.1%
Portfolio Holdings
76 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Alphabet Inc | 31.1K | $8.95M | 13.3% | +29.7K | Added |
| 2 | Ase Technology Hldg Co Ltd | 179.5K | $3.89M | 5.8% | +179.5K | New |
| 3 | Ionis Pharmaceuticals Inc | 39.0K | $2.93M | 4.4% | +14.0K | Added |
| 4 | Neurocrine Biosciences Inc | 21.6K | $2.84M | 4.2% | +18.0K | Added |
| 5 | Axsome Therapeutics Inc | 16.4K | $2.77M | 4.1% | +14.3K | Added |
| 6 | Biomarin Pharmaceutical Inc | 48.7K | $2.75M | 4.1% | +48.7K | New |
| 7 | Ascendis Pharma A/S | 11.8K | $2.71M | 4.0% | +8.8K | Added |
| 8 | Ptc Therapeutics Inc | 39.7K | $2.70M | 4.0% | +30.5K | Added |
| 9 | Pfizer Inc | 71.3K | $2.00M | 3.0% | +28.0K | Added |
| 10 | Regeneron Pharmaceuticals | 2.5K | $1.93M | 2.9% | +964 | Added |
66 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio